Pharmacy Times

JULY 23, 2025

J Clin Pharm Ther. 2021;46(5):1254-1262. doi:10.1111/jcpt.13419 13419 Gardenhire DS, Burnett D, Strickland S, Myers TR. A guide to aerosol delivery devices for respiratory therapists. American Association for Respiratory Care. Accessed June 6, 2025. link] Bosnic-Anticevich S, Bakerly ND, Chrystyn H, Hew M, van der Palen J.

Pharmacy Technician

Pharmacy Times

JUNE 27, 2025

In the 2017 book The Big Picture , author Sean Carroll seamlessly blends the scientific with the philosophical and comments that “life is not a substance, like water or rock; it’s a process, like fire or a wave crashing on the shore. Dutton; 2017. REFERENCES 1. The Big Picture: On the Origins of Life, Meaning, and the Universe Itself.

Pharmacy Technician

Pharmacy Times

JULY 7, 2025

million global deaths recorded in 2017. Updated October 16, 2017. The data, which were published in Nephrology , also highlighted comparable safety among the 2 treatments. The global prevalence is estimated to be about 11% to 13%, with 697.5 million cases of all-stage disease CKD and 1.2 ClinicalTrials.gov identifier: NCT02044653.

Pharmacy Technician

Pharmacy Times

JULY 8, 2025

These diseases are caused by a dysregulated mucosal immune response to the intestinal microflora in hosts who are genetically predisposed. One patient started Inflectra in 2016 and 2017. That same year, approximately 88% of the evaluated ImproveCareNow (ICN) Network centers were observed to be using biosimilars.

Biosimilars

pharmaphorum

JUNE 24, 2025

Skip to main content Tuesday 24 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Pharmacy Times

AUGUST 14, 2025

doi:10.1155/2017/7454376 Schwalfenberg GK. doi:10.1155/2017/6254836 Vanbuskirk S, Ruth Jessen Hickman M. The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review.  Int J Endocrinol. 2017;2017:7454376. Vitamins K1 and K2: The Emerging Group of Vitamins Required for Human Health. 

Pharmacy Technician

Pharmacy Times

JUNE 20, 2025

Updated July 14, 2017. If the bites worsen or signs of infection develop, if symptoms persist beyond a week, or if there are concerns about allergic reactions or fevers, he may need to visit a health care provider. 6 REFERENCES 1. Sun protection factor (SPF). Accessed May 12, 2025. Sunburn: treatment and prevention. Healthchildren.org.

Pharmacy Technician

BioPharma Dive

JUNE 27, 2025

Dive Insight: Since the FDA’s approval of Novartis’ Kymriah for leukemia in 2017, six more CAR-T therapies have reached market. These medicines are made from a patient’s own immune cells, extracted from the body and engineered in a lab to hunt down specific proteins found on the surface of malignant clones.

Drug Pricing

Putting Patients First Blog

JUNE 16, 2025

For example, incorporating immunization registries, social service data, and SDOH risk factors from trusted third-party sources would support holistic patient engagement tools. Developers would benefit from complementary integration with public sources such as the Area Deprivation Index and immunization registries. Harle, and Joshua R.

Documentation

Pharmacy Times

AUGUST 7, 2025

4 These findings led to the 2017 FDA approval of CPX-351 for adult patients with t-AML or AML-MRC. The study results showed that CPX-351 prolonged the time to hematologic count recovery but improved OS, particularly after allogeneic stem cell transplant (SCT), compared with the standard 7+3 chemotherapy regimen.

Chemotherapy

The Thyroid Pharmacist

AUGUST 1, 2025

Funny enough, in July 2017, on my 35th birthday, I told my husband I was ready to start a family, and went to a naturopathic clinic a few weeks later to get my labs done to prepare for pregnancy, when I realized my period was late! This provides the fetus with passive immunity from the mother, and helps protect it from infections.

Health and Personal Care Stores

pharmaphorum

AUGUST 13, 2025

Skip to main content Wednesday 13 August 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Diabetes

Beckers Hospital Review

AUGUST 8, 2025

Appointed chief of quality and patient safety in 2017, his focus on root cause analysis and staff engagement has significantly reduced hospital-acquired infections. Dr. Jarrett’s research experience has led to the publishing of his findings on the immune response in systemic lupus erythematosus, quality and cybersecurity in healthcare.

Hospitals

The Thyroid Pharmacist

MARCH 7, 2025

1] This inability to detox properly can trigger or worsen autoimmune symptoms, as these chemical exposures can trigger immune dysregulation. [2] A 2017 study analyzed 159 samples of tap water from around the world. [11] As I began my healing journey, I started paying closer attention to the toxins lurking in my environment.

Health and Personal Care Stores

The Thyroid Pharmacist

JULY 29, 2025

Her interview followed a series of women who had all experienced symptoms of immune disorders that could be traced back to their implants. There were reports of fatigue, swollen joints, and viral, bacterial, and fungal infections, along with a host of symptoms of immune deficiency appearing in women who had received the saline implants.

Immunity

Pharmaceutical Technology

AUGUST 13, 2025

Lilly was originally sued by the organisation in 2017, alleged to have participated in a “multi-tiered kickback scheme” along with other pharma companies, including Bayer. ” This referred to similar kickback claims previously made by Health Choice Alliance.

Packaging

pharmaphorum

JUNE 26, 2025

Skip to main content Thursday 26 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

pharmaphorum

JULY 17, 2025

Skip to main content Thursday 17 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Immunity

Pharmaceutical Technology

JUNE 16, 2025

A low incidence of immune effector cell-associated neurotoxicity syndrome was reported during the step-up dosing phase and the target dose phase. Two patients experienced dose-limiting toxicities and continued to receive the targeted dose.

Labelling

pharmaphorum

AUGUST 7, 2025

Skip to main content Thursday 7 August 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Diabetes

The Thyroid Pharmacist

MAY 9, 2025

Sex hormones have an influence on the immune system, so its no wonder that taking hormones in the form of birth control can affect the development of autoimmunity. A 2017 systematic review found a connection between hormonal contraceptives and an increased risk of developing several autoimmune conditions. [2]

Immunity

pharmaphorum

JULY 18, 2025

Skip to main content Friday 18 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

pharmaphorum

JULY 17, 2025

Skip to main content Thursday 17 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Immunity

pharmaphorum

AUGUST 17, 2020

Sanofi’s acquisition builds on a partnership to develop central nervous system drugs that began in late 2017. In a statement Sanofi said that the acquisition will give it full control of the brain-penetrant BTK inhibitor, SAR442168, making marketing more efficient and eliminating any royalty payments due under the 2017 agreement.

Immunization

pharmaphorum

JUNE 1, 2021

Patients will also receive a dose of tacrolimus, an immune-suppressing drug, to guard against any immune reaction to the transplanted cells. The hope is that the spheroids will help to replenish damaged cardiomyocytes in the heart, restoring some of its ability to pump blood around the body. Other readouts give grounds for optimism.

Immunity

ALiEM - Pharm Pearls

DECEMBER 18, 2023

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System. 2017 Jun 9;18(6):1243. Corticosteroids are the mainstay of treatment with gradual tapering over multiple months. References Cho YT, Yang CW, Chu CY. Int J Mol Sci. doi: 10.3390/ijms18061243.

Immunity

Pharmaceutical Technology

JUNE 12, 2023

CB1 is predominantly found in the central and peripheral nervous system, whereas CB2 is primarily located in immune cells. However, 2017 saw the discontinuation of nabiximols from Phase III development in the US for cancer pain, due to lack of efficacy.

Immunity

LifeProNow

APRIL 11, 2023

Nirsevimabhas been developed to offer newborns and infants direct RSV protection via an antibody to help prevent lower respiratory tract disease (LRTD) caused by RSV.Monoclonal antibodies do not require the activation of the immune system to help offer timely, rapid and direct protection against disease.

Immunity

pharmaphorum

MARCH 24, 2022

There’s a rich history of finding useful medicines from fungi, from the antibiotic penicillin to immune suppressant cyclosporine and cholesterol drug lovastatin. The examples remain few and far between, however, as in recent decades the pharma industry has turned its attention to synthetic molecules and biologics like antibodies.

Compounding

European Pharmaceutical Review

JANUARY 26, 2023

CAR T-cell therapy engineers a patient’s own immune cells (T-cells) to detect, target and destroy cancer cells. Of those who receive a transplant, about 50 percent will ultimately relapse, stated research from 2017, published in the journal Blood. Could CAR T therapies be manufactured in one day?

Chemotherapy

European Pharmaceutical Review

JANUARY 26, 2024

highlighted in the paper a key milestone achieved by the vaccine industry in 2017: “the first saponin adjuvant AS01 was approved for use in a human vaccine, the highly effective shingles vaccine Shingrix (produced by GSK).” “Our Martin et al. Our study opens unprecedented opportunities for bioengineering vaccine adjuvants.

Vaccines

pharmaphorum

DECEMBER 21, 2020

California-based Gilead announced its strong intentions in oncology in 2017 with its $11.9 Sanofi’s acquisition builds on a partnership to develop central nervous system drugs that began in late 2017. billion buy of Kite Pharma and followed that earlier this year by acquiring immuno-oncology firm Forty Seven for $4.9

Biosimilars

Express Pharma

APRIL 24, 2023

Adults above 50 years of age and those suffering from chronic conditions such as diabetes, heart disease and kidney diseases are at an increased risk of developing shingles because of weakened immunity. Shingrix was approved by the US Food and Drug Administration (FDA) for the prevention of shingles in adults 50 years of age or older in 2017.

Vaccines

European Pharmaceutical Review

MAY 4, 2023

Overall, the mechanisms of action for amivantamab include ligand blocking, receptor degradation, and immune cell-mediated activity. 4 BsMAb amivantamab was designed to enhance adherence of tumour cells to macrophages and natural killer cells, to improve immune-cell mediated killing of cancer cells. 2017; 8(43): 75712–26.

Immunity

Pharmaceutical Technology

DECEMBER 8, 2022

Kite Pharma and Daiichi Sankyo have updated a partnership agreement signed in 2017 for the former’s CAR T-cell therapy, Yescarta (axicabtagene ciloleucel). Directed against a cell membrane protein called CD19, Yescarta uses the immune system of the patient to destroy cancer.

Communication

pharmaphorum

APRIL 30, 2021

Janssen entered into a worldwide collaboration and license agreement for cilta-cel with the drug’s originator – China’s Legend Biotech – in December 2017. BMS and bluebird had been hoping for a label allowing third-line use.

Immunity

pharmaphorum

OCTOBER 28, 2021

The two companies have been working together since 2017, with Takeda pledging $100 million to help GammaDelta advance its cell therapy platform as part of a “build-to-buy” arrangement. T cells, a class of lymphocytes that play a role in a host of immune responses and immunopathologies.

Immunity